VanEck Associates’s Xylem XYL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $6.7M | Buy |
56,675
+6,767
| +14% | +$781K | ﹤0.01% | 757 |
|
|
2026
Q1 | $5.96M | Buy |
49,908
+4,092
| +9% | +$537K | ﹤0.01% | 755 |
|
|
2025
Q4 | $6.24M | Buy |
45,816
+38,754
| +549% | +$5.57M | 0.01% | 719 |
|
|
2025
Q3 | $1.04M | Buy |
7,062
+1,104
| +19% | +$153K | ﹤0.01% | 1081 |
|
|
2025
Q2 | $771K | Sell |
5,958
-1,101
| -16% | -$133K | ﹤0.01% | 1099 |
|
|
2025
Q1 | $843K | Buy |
7,059
+397
| +6% | +$49.2K | ﹤0.01% | 1065 |
|
|
2024
Q4 | $773K | Sell |
6,662
-38
| -0.6% | -$4.8K | ﹤0.01% | 1072 |
|
|
2024
Q3 | $883K | Buy |
6,700
+458
| +7% | +$61.3K | ﹤0.01% | 1010 |
|
|
2024
Q2 | $847K | Sell |
6,242
-843
| -12% | -$115K | ﹤0.01% | 1011 |
|
|
2024
Q1 | $915K | Sell |
7,085
-2,337
| -25% | -$282K | ﹤0.01% | 997 |
|
|
2023
Q4 | $1.08M | Buy |
9,422
+5,694
| +153% | +$568K | ﹤0.01% | 951 |
|
|
2023
Q3 | $339K | Buy |
3,728
+338
| +10% | +$34.9K | ﹤0.01% | 1094 |
|
|
2023
Q2 | $382K | Sell |
3,390
-4,920
| -59% | -$520K | ﹤0.01% | 1085 |
|
|
2023
Q1 | $870K | Buy |
8,310
+258
| +3% | +$26.9K | ﹤0.01% | 861 |
|
|
2022
Q4 | $890K | Buy |
8,052
+710
| +10% | +$74.4K | ﹤0.01% | 828 |
|
|
2022
Q3 | $642K | Sell |
7,342
-566
| -7% | -$51.4K | ﹤0.01% | 851 |
|
|
2022
Q2 | $618K | Buy |
7,908
+448
| +6% | +$37K | ﹤0.01% | 871 |
|
|
2022
Q1 | $636K | Buy |
7,460
+1,041
| +16% | +$99.7K | ﹤0.01% | 913 |
|
|
2021
Q4 | $770K | Buy |
6,419
+729
| +13% | +$90.5K | ﹤0.01% | 896 |
|
|
2021
Q3 | $704K | Buy |
5,690
+1,677
| +42% | +$216K | ﹤0.01% | 871 |
|
|
2021
Q2 | $481K | Buy |
4,013
+591
| +17% | +$67.5K | ﹤0.01% | 907 |
|
|
2021
Q1 | $359K | Buy |
3,422
+488
| +17% | +$49.5K | ﹤0.01% | 892 |
|
|
2020
Q4 | $298K | Buy |
2,934
+1,533
| +109% | +$144K | ﹤0.01% | 825 |
|
|
2020
Q3 | $118K | Buy |
1,401
+240
| +21% | +$18.7K | ﹤0.01% | 869 |
|
|
2020
Q2 | $75K | Buy |
1,161
+245
| +27% | +$16.2K | ﹤0.01% | 880 |
|
|
2020
Q1 | $60K | Buy |
916
+147
| +19% | +$11.6K | ﹤0.01% | 861 |
|
|
2019
Q4 | $61K | Sell |
769
-115
| -13% | -$8.95K | ﹤0.01% | 872 |
|
|
2019
Q3 | $70K | Buy |
884
+139
| +19% | +$10.9K | ﹤0.01% | 778 |
|
|
2019
Q2 | $62K | Sell |
745
-3,580
| -83% | -$285K | ﹤0.01% | 771 |
|
|
2019
Q1 | $342K | Buy |
+4,325
| New | +$316K | ﹤0.01% | 698 |
|
|
2016
Q4 | – | Sell |
-726
| Closed | -$38K | – | 907 |
|
|
2016
Q3 | $38K | Sell |
726
-15
| -2% | -$736 | ﹤0.01% | 807 |
|
|
2016
Q2 | $33K | Sell |
741
-46
| -6% | -$2K | ﹤0.01% | 799 |
|
|
2016
Q1 | $32K | Sell |
787
-17
| -2% | -$626 | ﹤0.01% | 755 |
|
|
2015
Q4 | $29K | Sell |
804
-207
| -20% | -$7.49K | ﹤0.01% | 739 |
|
|
2015
Q3 | $33K | Buy |
1,011
+302
| +43% | +$10.2K | ﹤0.01% | 732 |
|
|
2015
Q2 | $26K | Buy |
+709
| New | +$25.8K | ﹤0.01% | 763 |
|
Other funds holding XYL
VanEck Associates's XYL Position: Q2 2026 in Review
VanEck Associates increased its Xylem (XYL) stake by 14% in Q2 2026, buying an estimated $781K and bringing the position to 56,675 shares worth $6.7M. The position accounts for ﹤0.01% of the portfolio, ranked #757.
VanEck Associates first reported a position in XYL in Q2 2015 and has held it in 36 quarters since. 1,092 funds tracked by Wall St. Rank hold XYL as of Q2 2026.
- VanEck Associates held 56,675 shares of Xylem worth $6.7M as of Q2 2026.
- VanEck Associates bought 6,767 Xylem shares in Q2 2026, an estimated $781K.
- Xylem made up ﹤0.01% of VanEck Associates's portfolio in Q2 2026, its #757 holding.
- VanEck Associates first reported a position in Xylem in Q2 2015 and has held it in 36 quarters since.
- 1,092 funds tracked by Wall St. Rank held Xylem as of Q2 2026.
Based on VanEck Associates's 13F filing for Q2 2026, filed 14 Aug 2026.